The clinical outcome after inferior vena cava thrombosis in early infancy i
s unknown. We report the clinical long-term follow-up of 12 patients presen
ting inferior vena cava thrombosis within their first months of life (gesta
tional age: 24-41 weeks, follow-up: 7 +/- 3 years). Accompanying renal veno
us thrombosis occurred in 9, and adrenal bleeding in 4 patients. A central
venous catheter was related to the thrombosis in only four patients. Hetero
zygous factor V Leiden mutation was found in two of the eight infants witho
ut central venous catheter. Thrombolysis was performed in seven and effecti
ve in three infants: one infant required surgical thrombectomy. In three of
eight infants with ineffective or with no therapy, spontaneous recanalizat
ion occurred during follow-up. No patient died of the thrombosis. Although
no long-term anticoagulatory prophylaxis was performed, none of the childre
n with persisting occlusion (n = 5) or stenosis (n = 1) of the inferior ven
a cava developed symptomatic thrombo-embolic complications. However, extens
ive internal collaterals (n = 6), visible varicosis (n = 5), pain in the le
gs (n = 3) and persisting renal disease (n = 3) with arterial hypertension
(IZ = 2) were observed during follow-up.
Conclusion Inferior vena cava thrombosis of early infancy frequently persis
ts and may cause considerable long-term morbidity. New strategies for early
and long-term therapy are necessary.